Biopharma Business

Tag "Costs"

MEPs criticise lack of transparency on R&D costs

Price rises in the EU stir Members of European Parliament to discuss ways to make medicines more affordable, including increasing clarity on R&D costs New medicine prices in the EU

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here